Bookmark

Add to MyYahoo RSS

Biotech News

Biotech news continually updated from thousands of sources around the net.

27 min ago | PhysOrg Weblog

Ebola vaccine trials being fast-tracked: researchers

Safety trials on an Ebola vaccine are being fast-tracked, meaning it could be given to healthy volunteers as early as September, researchers said Thursday.

Comment?

Related Topix: Medicine, GlaxoSmithKline, Healthcare Industry

4 hrs ago | Business Journal

AmeriSource Bergen to add 185 jobs, expand into Conshohocken

AmerisourceBergen will expand its local operations by leasing and renovating Millennium III, an existing 70,000-square-foot office building in Conshohocken, and has committed to add 185 new jobs in the Philadelphia region over the next three years, Pennsylvania Gov. Tom Corbett said.

Comment?

Related Topix: AmerisourceBergen, Conshohocken, PA, US Governors, Tom Corbett, Chesterbrook, PA

Wed Aug 27, 2014

Reuters

InterMune drug may offer big upside to Roche if aimed at liver

Roche Holding AG's planned $8 billion purchase of InterMune Inc is centered around hopes for blockbuster sales of its lung drug, but the smaller company's development pipeline may end up giving the Swiss drugmaker a far bigger bang for its buck.

Comment?

Related Topix: InterMune, Medicine, Healthcare Industry, Health, Fibrosis, Food and Drug Administration

Business Journal

ModusLink takes 10 percent stake in Medifast

A supply chain and logistics company has taken a nearly 10 percent stake in Medifast over the last month - and left open the door to buying more.

Comment?

Related Topix: Medicine, Medifast, Healthcare Industry

KMIZ

Ebola virus

A Centers for Disease Control and Prevention staff member has returned to the United States from West Africa by charter flight after the employee had low-risk contact with a health worker who tested positive for Ebola.

Comment?

Related Topix: Centers for Disease Control and Prevention, Medicine, Healthcare Industry

Channel3000

Should you buy ISIS? No, not that one

You might think that a company called Isis Pharmaceuticals would be itching to change its name in order to avoid confusion with the terrorist organization Islamic State of Iraq and Syria .

Comment?

Related Topix: Isis Pharmaceuticals, Medicine, Healthcare Industry, Startups, Facebook, Social Software, Twitter

Reuters

Us Stocks-Futures point to flat open with indexes at records

U.S. stock index futures pointed to a flat open on Wednesday, as investors found few reasons to keep buying after a rally that has taken indexes to repeated records, even as there was little seen on the horizon that could derail the rally.

Comment?

Related Topix: Financial Markets, Allergan

Stanford

developed eye implant could work with smartphone to improve glaucoma treatments

Glaucoma, caused by rising fluid pressure in the eyes, is known as the silent thief of sight.

Comment?

Related Topix: Science / Technology

Forbes.com

Tuesday's ETF Movers: XBI, XLU

Our mission at Market News Video is to produce and distribute quality online videos about the stock markets and publicly traded companies.

Comment?

Related Topix: Arrowhead Research, Isis Pharmaceuticals, Medicine, Healthcare Industry, Financial Markets

Tue Aug 26, 2014

Sys-Con Media

IDEXX Laboratories marks 30th year with a new, LEEDA Gold Corporate Headquarters

As a whole, it is the heart of innovation within the IDEXX Corporation, and successfully concludes Phase II of the master plan crafted by Lavallee Brensinger Architects of , Principal-In-Charge at Lavallee Brensinger, IDEXX made its design objectives for the new 108,000 square foot building clear from the start.

Comment?

Related Topix: IDEXX Laboratories, Medicine, Healthcare Industry, Arts, Interior Design

Reuters

Allergan, facing shareholder demands, calls special meeting for December 18

Allergan Inc said on Tuesday that it has scheduled a special shareholders meeting for Dec. 18, when activist investor Bill Ackman, who supports a hostile bid for the company by Valeant Pharmaceuticals Inc, will attempt to oust most of its board.

Comment?

Related Topix: Allergan

Barron's

Biotech Stocks: Time to Worry

I mean, just look at these returns: Gilead Sciences has gained 41% so far this year as investors appear to have put their Sovaldi worries behind them ; InterMune has quintupled in 2014 after Roche agreed to purchase it for $8.3 billion ; and Intercept Pharmaceuticals has surged 350% as drug trials have been surprisingly good .

Comment?

Related Topix: Science / Technology, Financial Markets, Medicine, Gilead Sciences, Healthcare Industry, Startups, CGI Pharmaceuticals, InterMune

Reuters

Pfizer to test Xalkori lung cancer drug with Merck immunotherapy

Pfizer Inc said Tuesday it will test its Xalkori lung cancer drug with Merck & Co's experimental immunotherapy pembrolizumab, in the hopes the combination will improve the outcomes for patients taking the approved Pfizer therapy.

Comment?

Related Topix: Pfizer, Merck , Medicine, Healthcare Industry, Health, Lung Cancer

Iol.co.za

Roche pays $8.3bn for drug's potential

Swiss pharmaceutical company Roche Holding has agreed to buy US biotech company InterMune for $8.3 billion in cash in order to get hold of a promising respiratory drug, in the latest multibillion-dollar deal in a consolidating pharmaceutical and biotechnology sector.

Comment?

Related Topix: Science / Technology, Genentech, Startups, Reuters, Medicine, Pulmozyme, Dornase Alfa (generic), California

Business Journal

Biotech is in a microbial state in New York City, but Samuel Sia will let you use the Petri dish

Samuel K. Sia: "The biospace area is the one that has the most potential that people don't know about."

Comment?

Related Topix: Science / Technology, New York, Columbia University

Mon Aug 25, 2014

NewsTarget.com

New experimental GMOs cause Public outrage after USDA colludes with biotech industry

Despite a groundswell of opposition from watchdog groups, doctors, scientists, 50 members of Congress and thousands of members of the general public, the U.S. Department of Agriculture has decided to move forward with approval for three new genetically modified crops designed to be sprayed with Dow AgroScience's Enlist Duo herbicide, which contains ... (more)

Comment?

Related Topix: United States Department of Agriculture, US News, Agriculture, Science

UnionLeader.com

S&P 500 sets record high, can't hold 2,000

The significance of the milestone was more psychological than fundamental, and it represents the high point of a nearly six-year rally that has boosted retirement accounts for Americans from Wall Street to Main Street, though the gains have largely benefited wealthier Americans.

Comment?

Related Topix: Science / Technology, Financial Markets, Main Street and Main, Restaurant Management

Business Journal

CDC Foundation gets $1M grant to fight Ebola

Latest numbers from the CDC cite more than 2,600 cases of Ebola and 1,400 deaths reported in Guinea, Liberia, Nigeria and Sierra Leone, the four countries affected by the outbreak thus far.

Comment?

Related Topix: Centers for Disease Control and Prevention, Medicine, Healthcare Industry, Robert Wood Johnson Foundation, Charitable Organizations

WAPT-TV Jackson

Ebola: Your most pressing questions answered

The largest Ebola outbreak in history has struck fear into the hearts of people around the world.

Comment?

Related Topix: Centers for Disease Control and Prevention, Medicine, Healthcare Industry

The Globe and Mail

Valeant acquires dermatology portfolio and speciality products from Valeo

The head office and logo of Valeant Pharmaceutical are pictured in Montreal on Monday May 27, 2013.

Comment?

Related Topix: Medicine, Dermatology, Allergan

•••
•••
•••
•••

Biotech Jobs

•••
•••
•••
•••